Sickle cell disease
Would you like to receive a message when there is new research on Sickle Cell Disease? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence appears above each publication explaining what was studied — and you'll receive a notification as soon as there is new research about Sickle Cell Disease. View what Premium costs.
Publications and studies (2096)
- Sickle Cell Disease in Central India: Haematological and Clinical Insights from a Large Cohort of Patients. (2026/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Gene Therapy for Sickle Cell Anemia in India - Current Status and Challenges. (2026/03/01) ♡
- Cross-Cultural Adaptation, Reliability and Validity of MOS Short Form Health Survey (SF-36) in Sickle Cell Disease Patients in India. (2026/03/01) ♡
- Evaluation of Diagnostic Accuracy of Sickle SCAN™, and Gazelle™ for Screening Hemoglobin S in india. (2026/03/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Letter to the Editor: "Magnitude of Involvement of Peripheral Nervous System in Sickle Cell Anemia Patients in Vaso-Occlusive Crisis". (2026/03/01) ♡
- Impact of HBS1L-MYB Gene Single Nucleotide Polymorphisms on Fetal Hemoglobin Expression in Moroccan Sickle Cell Anemia Children: Preliminary Results. (2026/03/01) ♡
- Genetic and Functional Insights into F-Cell Distribution in Sickle Cell Anemia: A Genome-Wide Association Study Approach. (2026/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Expanding the Blood Donor Pool: An Update to Initiatives to Increase New Donor Participation. (2026/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Emerging Considerations in Transfusion Medicine: Hematopoietic Stem and Progenitor Cell Collection for Gene Therapy for Sickle Cell Disease and Transfusion-Dependent Thalassemia. (2026/03/01) ♡
- Heme-mediated Tau phosphorylation drives neurocognitive responses in sickle cell disease. (2026/03/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Global, regional, and national burden of Chagas disease, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. (2026/03/01) ♡
- Unveiling Bone Health in Sickle Cell Disease: A Comprehensive Analysis of Bone Mineral Density. (2026/03/01) ♡
- Association between absolute eosinophil count and outcomes in sickle cell disease vaso-occlusive episodes. (2026/03/01) ♡
- Host iron deficiency protects against Plasmodium infection and drives parasite molecular reprofiling. (2026/02/27) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Interventions to Prevent Post-Discharge Mortality among Children in Sub-Saharan Africa: A Systematic Review. (2026/02/17) ♡
- Gut microbiome profile among children and adolescents living with sickle cell disease: a protocol for systematic review and meta-analysis. (2026/02/16) ♡
- Low bone mineral density and pain impact in adults with sickle cell disease. (2026/02/10) ♡
- Identification of RBM3 as a novel regulator of human fetal hemoglobin expression. (2026/02/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case report: Sea Fan Retinopathy, an ocular anomaly of interest. (2026/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Toward a Generation Free From the Burden of Sickle Cell Disease: The Role of Global Partnerships in Public Health Advancement. (2026/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pediatric Clinicians' Guide to Nutrition and Growth in Children with Sickle Cell Disease. (2026/02/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Sickle Cell Disease: Expanding the Frontiers of Pathophysiology and Therapeutics. (2026/02/01) ♡
- Integrated Newborn Screening in Nigeria: The Way Forward, A Workshop Report. (2026/01/29) ♡
- Awareness and Acceptability of Prenatal Diagnosis of Sickle Cell Disease among Mothers of Affected Children in a Northern Nigerian Teaching Hospital. (2026/01/22) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Sickle Cell Disease at a Tertiary Care Center in the Vidarbha Region of India: Protocol for a Clinical and Observational Study. (2026/01/21) ♡
- Vitamin D deficiency in sickle cell disease: a neglected comorbidity in Tunisia. (2026/01/12) ♡
- Pain, sleep, fatigue, and health-related quality of life in pediatric sickle cell disease: a serial multiple mediator analysis. (2026/01/09) ♡
- Stakeholders' perspectives on the management and prevention of non-communicable diseases in rural Tanzania: SWOC analysis prior to PEN Plus implementation. (2026/01/05) ♡
- The impact of social vulnerability on primary vaccine coverage in children with sickle cell disease. (2026/01/05) ♡
- Analysis of risk factors for red blood cell alloimmunization and its incidence in hemoglobinopathy patients at a tertiary care center in Odisha, Eastern India. (2026/01/01) ♡
- Feasibility and acceptability of a new adapted physical activity program for children with chronic disease: a pilot study. (2026/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeting LncRNAs with CRISPR/Cas9 for Kidney Therapeutics: A Review. (2026/01/01) ♡
- Magnitude of Involvement of Peripheral Nervous System in Sickle Cell Anemia Patients in Vaso-Occlusive Crisis. (2026/01/01) ♡
- Empowered Prenatal Choice-Making as a Simple Tool to Reduce Disease Burden in Severe Haemoglobinopathies by HBB Gene Variant Analysis, Prenatal Diagnosis and Genetic Counselling. (2026/01/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. CRISPR/Cas9 System as a Promising Therapy in Thalassemia and Sickle Cell Disease: A Systematic Review of Clinical Trials. (2026/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Beyond newborn screening: the role of reverse cascade testing in familial disease detection. (2026/01/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Blood-based protein biomarkers of sickle cell disease pain: a systematic review and meta-analysis. (2026/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Inflammatory Bowel Disease Following Allogeneic Hematopoietic Cell Transplant for Sickle Cell Disease. (2026/01/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Hospital Variations in Time-To-Crisis-Resolution Among Children and Adolescents With Sickle Cell Disease. (2026/01/01) ♡
- Assessment of Knowledge, Attitudes and Practices Regarding Sickle Cell Disease in Souza, Cameroon. (2026/01/01) ♡
- Mapping the Research Growth and Citation Impact of Scholarly Works on Sickle Cell Disease in Tanzania: A Scientometric Study. (2026/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Gene Therapy Communication: Use of a Needs Assessment to Drive Decision-AIDS for Gene Therapy for Rare Diseases (GENETX) (2026-08-10) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Support Strategies for Parents During the First Year Following Their Child's Diagnosis of Sickle Cell Disorder (2026-08-07) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Feasibility and Acceptability of Amani (2026-08-07) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Standard of Care Comparative Arm of Phase 1/2 Gene Therapy Trial DREPAMIR" in Severe Sickle Cell Disease Patients (2026-08-07) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants (2026-08-07) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pathophysiology of Acute Pain in Patients With Sickle Cell Disease (2026-08-07) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Domestication and Implementation of the PEN-Plus Clinical Model in the Zambian Health System (2026-08-07) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. A Safety, Efficacy, and Pharmacokinetic (PK) Study of HBI-002, an Oral Carbon Monoxide (CO) Therapeutic, in Subjects With Sickle Cell Disease (SCD) (2026-08-06) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD) (2026-08-05) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.